Viewing Study NCT00482703


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-06-14 @ 2:45 AM
Study NCT ID: NCT00482703
Status: COMPLETED
Last Update Posted: 2010-12-17
First Post: 2007-06-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Leukemia, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Imatinib resistant or intolerant chronic phase CML View